Membership Directory
MedImmune, Inc.
Category: Drug Development
Phone: + (617) 323-1172
Fax: + (617) 323-1173
Website: http://www.medimmune.com
Location: Gaithersburg, MD
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer, and inflammatory diseases. The company has four marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life-threatening diseases. MedImmunes new state-of-the-art R&D facility and worldwide corporate headquarters is located in Gaithersburg, Maryland. With approximately 1,900 employees worldwide, MedImmune is headquarted in Maryland with facilities in Pennsylvania, California, Kentucky, and the United Kingdom and the Netherlands. The company relocated its corporate headquarters to a new state-of-the-art facility in March 2004, designed to place research functions at the core and enhance the collaborative potential of researchers and developers. The companys marketed products include Synagsis (palivizumab), Ethyol (amifostine), FluMist (influenza virus vaccine live, intranasal), and CytoGam (cytomegalovirus immune globulin intravenous (human)), with additional products in clinical testing.
Back to list